Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2025-12-24 @ 11:59 AM
NCT ID:
NCT01652261
Eligibility Criteria:
Inclusion criteria:
* Previously untreated, histologically proven classical Hodgkin lymphoma
* Clinical stages III/IV (Ann Arbor)
* Age 18-60
* WHO performance 0-2
* Adequate organ function
* Patients of childbearing/reproductive potential should use adequate birth control measures during the whole duration of study treatment.
* Written informed consent according to ICH/EU Good Clinical Practice, and national/local regulations
Exclusion criteria:
* Pregnancy or lactation
* Specific contraindications to BEACOPPesc therapy, including:
* Poorly controlled diabetes mellitus
* HIV infection,
* Chronic active hepatitis B and/or hepatitis C
* Concomitant or previous malignancies with the exception of basal cell skin tumors, adequately treated carcinoma in situ of the cervix and any cancer that has been in complete remission for \>5 years
* Psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT01652261
Study Brief:
Protocol Section:
NCT01652261